These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 13830100)

  • 1. Theoretical considerations in parkinsonism induced by tranquilizing drugs.
    GUGGENHEIM P; COHEN L
    Dis Nerv Syst; 1959 Aug; 20():346-52. PubMed ID: 13830100
    [No Abstract]   [Full Text] [Related]  

  • 2. Reversibility of drug-induced parkinsonism.
    CAHAN RB; PARRISH DD
    Am J Psychiatry; 1960 May; 116():1022-3. PubMed ID: 13806781
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experiences and conclusions in regard to the use of hirepin. Part I].
    GOLDSCHMIDT D
    Ideggyogy Sz; 1960 Apr; 13():97-103. PubMed ID: 13850736
    [No Abstract]   [Full Text] [Related]  

  • 4. Psychomotility and parkinsonism in treatment with neuroleptic drugs.
    FREYHAN FA
    AMA Arch Neurol Psychiatry; 1957 Nov; 78(5):465-72. PubMed ID: 13468837
    [No Abstract]   [Full Text] [Related]  

  • 5. AN EXPERIMENTAL STUDY OF THE NEUROPATHOLOGICAL AND TOXICOLOGICAL EFFECTS OF CHLORPROMAZINE AND RESERPINE.
    MACKIEWICZ J; GERSHON S
    J Neuropsychiatr; 1964 Feb; 5():159-69. PubMed ID: 14118070
    [No Abstract]   [Full Text] [Related]  

  • 6. [Parkinsonian syndrome following prolonged administration of chlorpromazine with fatal concomitant stroke. Appearance of pallidal lesions].
    POURSINES Y; ALLIEZ J; TOGA M
    Rev Neurol (Paris); 1959 Jun; 100():745-51. PubMed ID: 14434527
    [No Abstract]   [Full Text] [Related]  

  • 7. [POISONING BY THYMOLEPTICS AND TRANQUILIZERS].
    FOURNIER E
    Gaz Med Fr; 1964 Sep; 71():2851-67. PubMed ID: 14192480
    [No Abstract]   [Full Text] [Related]  

  • 8. [COMPLICATIONS OF NEUROLEPTICS].
    NEHLIL J
    Clinique (Paris); 1963 Oct; 58():595-9. PubMed ID: 14092600
    [No Abstract]   [Full Text] [Related]  

  • 9. Protection against reserpine-induced Parkinsonism.
    RASHKIS HA; SMARR ER
    Am J Psychiatry; 1957 Jun; 113(12):1116. PubMed ID: 13424739
    [No Abstract]   [Full Text] [Related]  

  • 10. Parkinsonism as a result of treatment with reserpine, report of a case.
    BROWNE J
    Med J Malaya; 1956 Mar; 10(3):262-3. PubMed ID: 13347457
    [No Abstract]   [Full Text] [Related]  

  • 11. [The significance of reserpine-induced parkinsonism for the treatment of schizophrenia].
    BAYREUTHER H
    Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr; 1958; 197(2):215-22. PubMed ID: 13534618
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effects of high-dosed reserpin (serpasil) treatment and drug-induced parkinsonism-like states on the electroencephalogram].
    BENTE D; ITIL T
    Med Klin; 1955 Aug; 50(31):1296-301. PubMed ID: 13265093
    [No Abstract]   [Full Text] [Related]  

  • 13. [COMPLICATIONS DURING CLINICAL THERAPY WITH PSYCHOPHARMACA].
    HAEFNER H; KUTSCHER I
    Arztl Forsch; 1964 Jan; 18():18-36. PubMed ID: 14140626
    [No Abstract]   [Full Text] [Related]  

  • 14. ASYPHYXIA RELATIVELY INHERENT TO TRANQUILIZATION. REVIEW OF THE LITERATURE AND REPORT OF SEVEN CASES.
    PLACHTA A
    Arch Gen Psychiatry; 1965 Feb; 12():152-8. PubMed ID: 14237625
    [No Abstract]   [Full Text] [Related]  

  • 15. AN APPARENTLY IRREVERSIBLE SYNDROME OF ABNORMAL MOVEMENTS FOLLOWING PHENOTHIAZINE MEDICATION.
    HUNTER R; EARL CJ; THRONICROFT S
    Proc R Soc Med; 1964 Aug; 57(8):758-62. PubMed ID: 14195882
    [No Abstract]   [Full Text] [Related]  

  • 16. [ON THE ANTAGONISM OF THE ACTION OF NEUROLEPTICS AND ANTIPARKINSON AGENTS].
    ZSCHUCKE CF
    Nervenarzt; 1964 May; 35():217-21. PubMed ID: 14182811
    [No Abstract]   [Full Text] [Related]  

  • 17. [Drug-induced parkinsonism and its treatment with Akineton].
    ROSEN A
    Ther Umsch; 1963 Jan; 20():9-12. PubMed ID: 13974823
    [No Abstract]   [Full Text] [Related]  

  • 18. [EXTRAPYRAMIDAL SYMPTOMS DUE TO THE USE OF PSYCHOPHARMACA].
    BOHACEK N; HAJNSEK F; SARTORIUS N
    Fortschr Neurol Psychiatr Grenzgeb; 1963 Oct; 31():565-70. PubMed ID: 14095902
    [No Abstract]   [Full Text] [Related]  

  • 19. [PSYCHOPHARMACA: OBSERVATIONS AND INTERPRETATIONS].
    DESCHAEPDRYVER A
    Belg Tijdschr Geneesk; 1964 Dec; 20():1265-76. PubMed ID: 14261099
    [No Abstract]   [Full Text] [Related]  

  • 20. [Definition and mode of action of the psychomotor Parkinson syndrome therapeutically induced by serpasil and largactil].
    HAASE HJ
    Monatsschr Psychiatr Neurol; 1956 Apr; 131(4):201-14. PubMed ID: 13334283
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.